# Glucagon Modulation of Ghrelin Secretion

> **NCT00929812** · PHASE3 · UNKNOWN · sponsor: **Charite University, Berlin, Germany** · enrollment: 38 (actual)

## Conditions studied

- Healthy Subjects
- Obesity
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Glucagon hydrochloride (GlucaGen®)
- **DRUG:** NaCl 0.9%

## Key facts

- **NCT ID:** NCT00929812
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-06
- **Primary completion:** 2008-01
- **Final completion:** 2009-12
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2009-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00929812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00929812, "Glucagon Modulation of Ghrelin Secretion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00929812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*